Drug or treatment
Eculizumab clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Eculizumab that are recruiting, at sites in 6 countries (most in France (2), China (2), Canada (1)). By phase: Phase 3 (2), Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Eculizumab for high-risk TA-TMA in adult HSCT recipients | Phase 2 | Changsha, Hunan and 7 other locations | Recruiting | Jul 16, 2026 |
| Acute treatments for AQP4-positive NMOSD attacks | Phase 4 | Beijing | Recruiting | Feb 13, 2026 |
| Rituximab vs multiple approved NMOSD therapies to prevent relapses | Phase 4 | Boston, Massachusetts and 2 other locations | Recruiting | Jun 8, 2025 |
| Evaluating Danicopan with Ravulizumab or Eculizumab for Pediatric PNH Patients | Phase 3 | Saskatoon, Saskatchewan and 3 other locations | Recruiting | Jun 7, 2024 |
| Eculizumab for treating hemolytic uremic syndrome linked to hypertensive emergencies | Phase 3 | Paris | Recruiting | Feb 14, 2023 |
All recruiting trials (5)
-
Eculizumab for high-risk TA-TMA in adult HSCT recipients
This trial tests whether eculizumab can help adults with high-risk TA-TMA after allogeneic stem cell transplantation.
-
Acute treatments for AQP4-positive NMOSD attacks
This project will test whether adding eculizumab or IVIG to high-dose IV steroid pulses helps adults with AQP4-positive NMOSD during an acute attack.
-
Rituximab vs multiple approved NMOSD therapies to prevent relapses
This study tests whether rituximab or one of four other approved medicines is better at preventing NMOSD relapses in adults who have AQP4-IgG.
-
Evaluating Danicopan with Ravulizumab or Eculizumab for Pediatric PNH Patients
This study is testing if adding danicopan to the current treatments of ravulizumab or eculizumab can help kids with PNH have better hemoglobin levels.
-
Eculizumab for treating hemolytic uremic syndrome linked to hypertensive emergencies
This study is testing if Eculizumab can help people with kidney problems caused by severe high blood pressure feel better and recover faster.
Quick answers
How many clinical trials of Eculizumab are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in France (2 trials), China (2 trials), Canada (1 trial), United Kingdom (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.